Trademark: 86600429
Status Date
Wednesday, November 4, 2015
Filing Date
Thursday, April 16, 2015
Published for Opposition
Tuesday, September 15, 2015
Abandoned Date
Wednesday, November 4, 2015
5 Oral, transdermal, injectable and intravaginal contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungals; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; pharmaceutical preparations for use as a neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Feb 19, 2020
Assignment Of Ownership Not Updated Automatically
Jun 21, 2017
Automatic Update Of Assignment Of Ownership
Nov 4, 2015
Abandonment Notice Mailed - After Publication
Nov 4, 2015
Abandonment - After Publication
Nov 2, 2015
Teas Express Abandonment Received
Oct 12, 2015
Extension Of Time To Oppose Received
Sep 15, 2015
Official Gazette Publication Confirmation E-Mailed
Sep 15, 2015
Published For Opposition
Aug 26, 2015
Notification Of Notice Of Publication E-Mailed
Aug 13, 2015
Law Office Publication Review Completed
Aug 7, 2015
Assigned To Lie
Jul 27, 2015
Approved For Pub - Principal Register
Jul 27, 2015
Examiner's Amendment Entered
Jul 27, 2015
Notification Of Examiners Amendment E-Mailed
Jul 27, 2015
Examiners Amendment E-Mailed
Jul 27, 2015
Examiners Amendment -Written
Jul 24, 2015
Assigned To Examiner
Apr 24, 2015
New Application Office Supplied Data Entered In Tram
Apr 20, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
